IP Verse

Torrejon Nieto patent opposition analysis

The comprehensive analysis of Torrejon Nieto opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Torrejon Nieto

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP2285410	Dpp-Iv Inhibitor Combined With A Further Antidiabetic Agent, Tablets Comprising Such Formulations, Their Use And Process For Their Preparation	BOEHRINGER INGELHEIM	Jun 25, 2019	GALENICUM HEALTH SLU
EP2827885	Compositions Of Glp-1 Peptides And Preparation Thereof	NOVO NORDISK	May 15, 2019	GALENICUM HEALTH SLU
EP2991671	Oral Dosing Of Glp-1 Compounds	NOVO NORDISK	May 15, 2019	GALENICUM HEALTH SLU
EP2896397	Novel Compounds Having Inhibitory Activity Against Sodium-Dependant Glucose Transporter	MITSUBISHI TANABE PHARMA	Jun 6, 2018	GALENICUM HEALTH SL
EP2986281	Oral Formulation For The Treatment Of Cardiovascular Diseases	FERRER INTERNACIONAL	Sep 21, 2017	GALENICUM HEALTH SL

Top companies who are the clients of Torrejon Nieto

Company	Total
GALENICUM HEALTH SLU	3
GALENICUM HEALTH SL	2